Summary
Shorter overall treatment time with radiotherapy (RT) appears to improve outcomes in patients with non—small cell lung cancer (NSCLC) compared with longer overall treatment time. This article outlines optimal RT dose and fractionation for concurrent and sequential schedules for stage III NSCLC.
- Respiratory Cancers
- Radiology
- Radiation Therapy
- Cancer
- Respiratory Cancers
- Radiology
- Radiation Therapy
- Oncology
- Cancer
- © 2014 MD Conference Express®
Tools
Table of contents
Cited By...
- No citing articles found.